A Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy
Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out the optimal dose for Remimazolam Tosilate as a
procedural sedative during a diagnostic upper GI endoscopy and to assess its efficacy and
safety profile comparing to propofol.